摘要
Aim: This study aims to investigate whether osteoprotegerin (OPG) or osteopontin (OPN) single nucleotide polymorphisms (SNPs) will predict survival. Materials & methods: This study enrolled 617 participants undergoing health examination, 536 coronary artery disease (CAD) patients and 86 peripheral artery disease (PAD) patients. Genotypes of OPG SNP rs2073618 and OPN SNP rs11730582 were determined. OPG and OPN levels were measured. Results: In both CAD and PAD populations, high OPG and OPN levels were strong predictors of all-cause death. The OPG rs2073618 CC genotype and the OPN rs11730582 TT genotype did not predict mortality. Conclusion: High OPG and high OPN levels, but not OPG rs2073618 CC genotype or OPN rs11730582 TT genotype, were strong predictors of mortality in both CAD and PAD patients.
| 原文 | 英語 |
|---|---|
| 頁(從 - 到) | 751-760 |
| 頁數 | 10 |
| 期刊 | Biomarkers in Medicine |
| 卷 | 13 |
| 發行號 | 9 |
| DOIs | |
| 出版狀態 | 已出版 - 2019 |
文獻附註
Publisher Copyright:© 2019 Future Medicine Ltd.
UN SDG
此研究成果有助於以下永續發展目標
-
SDG3 健康與福祉
指紋
深入研究「Osteoprotegerin and osteopontin levels, but not gene polymorphisms, predict mortality in cardiovascular diseases」主題。共同形成了獨特的指紋。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver